What is Integrated Nano-Technologies?
Integrated Nano-Technologies (INT) operates at the intersection of molecular biology and advanced engineering, specializing in the development of sophisticated biological identification systems. The company's flagship Palladium System represents a paradigm shift in diagnostic capabilities, offering physicians and veterinary professionals the ability to conduct rapid disease identification and high-precision genetic testing. By streamlining the diagnostic workflow, INT addresses critical inefficiencies in clinical settings, providing actionable data that facilitates faster patient outcomes and improved therapeutic decision-making. The firm's market position is defined by its commitment to miniaturized, high-throughput diagnostic hardware that bridges the gap between laboratory-grade accuracy and point-of-care accessibility.
How much funding has Integrated Nano-Technologies raised?
Integrated Nano-Technologies has raised a total of $354K across 2 funding rounds:
Debt
$150K
Debt
$204K
Debt (2020): $150K with participation from PPP
Debt (2021): $204K led by PPP
Key Investors in Integrated Nano-Technologies
PPP
Public-Private Partnership
What's next for Integrated Nano-Technologies?
With the successful closure of this late-stage financing, Integrated Nano-Technologies is poised to enter a phase of aggressive market penetration and infrastructure expansion. The strategic roadmap likely involves scaling the manufacturing capacity of the Palladium System to meet growing demand across global healthcare networks. Furthermore, the company is expected to prioritize regulatory milestones and clinical validation studies to broaden the diagnostic scope of its technology. As INT matures, the focus will shift toward establishing long-term partnerships with major healthcare providers and diagnostic laboratories, ensuring the Palladium System becomes a standard component of modern clinical infrastructure. This capital infusion provides the necessary runway to solidify the company's competitive moat in the rapidly evolving molecular diagnostics landscape.
See full Integrated Nano-Technologies company page
